INMED Flashcards

(25 cards)

1
Q

Which HLA are associated with T1DM

A

Positive HLA-DR4 and HLA-DR3 association

“If you buy 4 DiaMonds and only pay for 3, you get 1 for free:” DR4 and

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which type of diabetes is associated with ketoacidosis

A

T1DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which medications are known to increase the risk of T2DM

A

Glucocorticoids
Statins
Thiazide diuretics
Some HIV medications
Second generation antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the inheritance of MODY

A

autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the prognosis and treatment for MODY II

A
  • There is no increased risk of microvascular disease.
  • Despite stable hyperglycemia and chronically elevated HbA1C levels, MODY II can be managed with diet alone.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the indications for testing a pt <35 for diabetes

A

Are overweight or obese AND have ≥ 1 of the following risk factors:
* First-degree relative with diabetes
* High-risk race or ethnicity
* CVD
* PCOS
* HTN
* Obese/ HLD

Have prediabetes or a history of gestational diabetes
Have any risk-enhancing comorbidities, including:
HIV infection
Cystic fibrosis
Post organ transplant
Pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the testing timelines for diabetes screenign

A

If results are normal, repeat testing in asymptomatic patients at least every three years.

Patients with prediabetes should be tested annually.

Patients with a history of gestational diabetes should be tested at least every three years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the diagnositic criteria for diabetes

A
  • Random blood glucose level ≥ 200 mg/dL in patients with symptoms of hyperglycemia (i.e., polydipsia, polyuria, polyphagia, unexplained weight loss) or hyperglycemic crisis
  • OR ≥ 2 abnormal test results for hyperglycemia in asymptomatic individuals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what conditions may leads to a falsely low A1c

A
  • Decreased RBC lifespan: e.g., due to acute blood loss, hemoglobinopathies such as sickle cell trait/disease, thalassemia, G6PD-deficiency, cirrhosis, hemolytic anemia, splenomegaly, antiretroviral drugs
  • Increased erythropoiesis: e.g., due to EPO therapy, reticulocytosis, pregnancy (second and third trimesters), iron supplementation
  • Altered hemoglobin: high-dose vitamin C and E supplementation

Significant discrepancy between HbA1c and glucose measurements warrants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is A1c indicates diabetes?

A

> 6.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what A1c might indicate prediabetes? What else could it mean?

A

5.7 -6.4%

HbA1c at this level does not allow for a definitive diagnosis; an OGTT or fasting glucose test is necessary to differentiate between diabetes mellitus, impaired glucose tolerance, and normal (healthy) glucose metabolism.

100–125 mg/dL (5.6–6.9 mmol/L) = impaired fasting glucose
140–199 mg/dL (7.8–11.0 mmol/L) = impaired glucose tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pts aged 40-75 years with diabetes should initiate what therapy regardless of lipid levels

A

moderate intensity statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the glycemic targets in diabetes

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the known causes of early morning hyperglycemia in diabetes pts

A

Dawn phenomenon: A physiological increase of growth hormone levels in the early morning hours stimulates hepatic gluconeogenesis and leads to a subsequent increase in insulin demand that cannot be met in insulin-dependent patients, resulting in elevated blood glucose levels.

Somogyi effect: Nocturnal hypoglycemia due to evening insulin injection triggers a counterregulatory secretion of hormones , leading to elevated blood glucose levels in the morning.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the first line treatment for T2DM and when should it be started

A

Metformin monotherapy started at diagnosis

Metformin should be part of every patient’s treatment, unless contraindicated, and continued for as long as it is tolerated, as it is safe, effective, widely available, and has been shown to reduce cardiovascular events and mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the drug class for metformin

17
Q

what drugs are included in the Dipeptidyl peptidase-4 inhibitors

A

Sitagliptin
Saxagliptin (avoid in CHF pt)
Linagliptin

18
Q

what drugs are included in the SGLT-2 inhibitors and who should they be used with?

A

Empagliflozin

  • Recommended for patients with CKD and confirmed eGFR 15-29 mL/min/1.73 m2
  • Consider in patients with clinical ASCVD or high risk of ASCVD, chronic kidney disease, or congestive heart failure.
  • Beneficial for patients who need to lose or maintain their weight
19
Q

what drugs are included in the SGLP-1 receptor agonists and who should they be used with?

A

Semaglutide
liraglutide

  • eGFR <30
  • ASCVD
  • weight loss
20
Q

what drugs are included in the Sulfonylureas and what are the benefits of these drugs

A

Glimepiride

has a low risk of hypoglycemia

21
Q

what drugs are included in the Thiazolindinediones

22
Q

what is the rate at which oral monotherapy lowers A1c levels. How can it be increased?

A

Oral monotherapy usually lowers HbA1c levels by ∼ 1%. Every noninsulin drug added to metformin will lower the HbA1c by an additional ∼ 0.7–1.0%

23
Q

combining what drug class with insulin with increase the risk of hypoglycemia

A

sulfonylureas (Glimepiride)

24
Q

what are the indications for insuling therapy in T2DM pts

A
  • non-response to sufficient treatment
  • contraindications for noninsulin antidiabetic drugs, e.g., patients with end-stage renal failure
  • Pregestational and gestational diabetes
  • Hyperglycemic crisis

Consider in newly diagnosed patients with any of the following:
* Initial glucose ≥ 300 mg/dL or HbA1c > 10%
* Symptoms of hyperglycemia
* Signs of a continued catabolic state, e.g., weight loss

Start with the simplest insulin regime, i.e., a basal insulin regimen with once-daily injections

25